Suppr超能文献

从洞察到 CXCR4 和 ACKR3(CXCR7)功能的调节。

From Insight to Modulation of CXCR4 and ACKR3 (CXCR7) Function.

机构信息

Division of Medicinal Chemistry, Amsterdam Institute for Molecules Medicines and Systems, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands

Division of Medicinal Chemistry, Amsterdam Institute for Molecules Medicines and Systems, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

出版信息

Mol Pharmacol. 2019 Dec;96(6):735-736. doi: 10.1124/mol.119.118364. Epub 2019 Oct 17.

Abstract

Chemokine receptors CXCR4 and atypical chemokine receptor 3 (ACKR3/CXCR7) are highly expressed in a range of tumors. Yet, their role in cancer progression is not well understood. This minireview series encompasses seven comprehensive reviews focusing on modulators (small molecules, pepducins, antibodies), structural aspects, spatio-temporal signaling properties, and phosphorylation/interactome of CXCR4 and ACKR3. Moreover, different (patho)physiologic aspects and roles of these receptors in immunologic and oncogenic processes are discussed. SIGNIFICANCE STATEMENT: CXCR4 and atypical chemokine receptor 3 are two oncogenic G protein-coupled receptors that are highly upregulated in various tumors. Insight into the signalling properties of these receptors and the availability of modulators targeting these receptors are essential to assess their role in cancer.

摘要

趋化因子受体 CXCR4 和非典型趋化因子受体 3(ACKR3/CXCR7)在多种肿瘤中高度表达。然而,它们在癌症进展中的作用尚不清楚。本综述系列包括七篇综述,重点介绍了趋化因子受体 CXCR4 和 ACKR3 的调节剂(小分子、肽聚糖、抗体)、结构方面、时空信号特性和磷酸化/相互作用组。此外,还讨论了这些受体在免疫和致癌过程中的不同(病理)生理方面和作用。意义陈述:趋化因子受体 CXCR4 和非典型趋化因子受体 3 是两种致癌的 G 蛋白偶联受体,在各种肿瘤中高度上调。深入了解这些受体的信号特性以及针对这些受体的调节剂的可用性对于评估它们在癌症中的作用至关重要。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验